Pfizer and Allergan plc announced today that the merger agreement between the two companies has been terminated by mutual agreement.Pfizer said in a press release that the decision was based on actions announced by the U.S. Department of Treasury on April 4, “which the companies concluded qualified as an ‘Adverse Tax Law Change’ under the merger agreement.”
Pfizer and Allergan plc announced today that the merger agreement between the two companies has been terminated by mutual agreement.Pfizer said in a press release that the decision was based on actions announced by the U.S. Department of Treasury on April 4, “which the companies concluded qualified as an ‘Adverse Tax Law Change’ under the merger agreement.”
At Hawaiian Eye, Roger A. Dailey, MD, FACS, discusses treatment options for nasolacrimal duct obstruction, flaccid canaliculi, punctal occlusion, triachiasis and distichiasis.
Visunex Medical Systems has received CE mark for the PanoCam LT wide-field imaging system, according to a press release.The PanoCam system is a compact, wireless system used for detecting vision disorders in premature and newborn babies, and may be use…
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY) a biopharmaceutical company focusing on commercializing its Avenova® Lid and Lash Cleanser for the domestic eye care market, announces that it has entered into a securities purchase agreement for the sale of its common stock and warrants in a private placement to accredited investors for $11.791 million. The financing structure is a commitment by investors to participate in two tranches. The first tranche closin
Status: Active, not recruiting,
Condition Summary: Retinitis Pigmentosa; Retinal Degeneration